You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GYRE Sale Disclosure
Ye Weiguo · SEC Form 4 · Filed Jun 22, 2026
Sale
Calculated transaction value
$19.05K
Ye Weiguo Chief Operating Officer
GYRE
Gyre Therapeutics
GYRE
Transaction date
Jun 18, 2026
Public filing date
Jun 22, 2026
Filing lag
Filed 4 days later
GYRE daily price context
Close on/before transaction
$6.25
Jun 18, 2026
First close after public filing
$6.13
Jun 23, 2026
30-day return after filing
-3.1%
Through Jul 22, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,000 shares @ $6.35
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001140361-26-025950
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$76.95K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Gyre Therapeutics, Inc. GYRE | Exercise | Jun 18, 2026 | $2.25K |
| Gyre Therapeutics, Inc. GYRE Current | Sale | Jun 18, 2026 | $19.05K |
| Gyre Therapeutics, Inc. GYRE | Exercise | Jun 18, 2026 | $0 |
| Gyre Therapeutics, Inc. GYRE | Sale | Jun 10, 2026 | $31.2K |
| Gyre Therapeutics, Inc. GYRE | Exercise | Jun 10, 2026 | $0 |
| Gyre Therapeutics, Inc. GYRE | Exercise | Jun 10, 2026 | $3.75K |
| Gyre Therapeutics, Inc. GYRE | Exercise | Jun 9, 2026 | $2.25K |
| Gyre Therapeutics, Inc. GYRE | Exercise | Jun 9, 2026 | $0 |
| Gyre Therapeutics, Inc. GYRE | Sale | Jun 9, 2026 | $18.45K |